Infection Surveillance Solutions Market with COVID-19 Impact Analysis, By Product & Service (Software Web-Based On-Premise Services Implementation Services Product Support & Maintenance Training & Consulting services), By End User (Hospitals Medical Long Term Care Facilities), and by Region (NA, EU, APAC, LA, MEA) Analysis, Size, Share, Trends, & Forecast from 2021-2027
REPORT HIGHLIGHT
The global Infection Surveillance Solutions market was valued at USD 490.7 Million in 2020, growing with a 7.8% CAGR during the forecast period, 2021-2027.
Infection surveillance alternatives are technology and interconnected organizations which support to a collection of medical information related to concerning the factors designed to cause healthcare-associated infectious diseases in medical centers and provide characteristics to supervise, evaluate, regulate, and produce a control intervention process to minimize and inhibit HAIs.
Market Dynamics
The worldwide infectious disease surveillance assistance industry is being driven primarily by an increment in the occurrence of universal health care infectious diseases, an improvement in financial support from corporate and public sector institutions for numerous infectious disease surveillance initiatives, a boost in the multitude of surgeries, a raise in the aging populations, that further is more vulnerable to healthcare-associated infectious diseases, and a boost in the implementation of infectious disease monitoring application between many health professionals.
Following the outbreak, the medical industry for Infectious Monitoring Systems is likely to increase significantly. Following the outbreak, the health industry for Disease Surveillance Systems is likely to increase significantly. Owing to curfews, travel restrictions, and company closures, the COVID-19 has had an impact on businesses and enterprises in a number of nations. The COVID-19 problem has overwhelmed many nations' public health infrastructure, highlighting the critical requirement for long-term funding for healthcare schemes. As the COVID-19 outbreak spreads, the medical industry's development is projected to slow. The biosciences industry is thriving as a result of the growing demand for cultured cells diagnostics goods and expanded R&D efforts throughout the globe.
The industry for disease surveillance technology, on the other hand, is hampered by a lack of information management and computational capabilities. Inadequate and erroneous data about a patient’s health background and care leads to false conclusions in monitoring programs as a consequence of poor information handling. This could render it tough to analyze patient information and surgical records on schedule, which is expected to restrict the global growth of the Disease Surveillance Technologies Industry in the upcoming decades.
Segmentation Analysis:
The Infection Surveillance Solutions market is segmented on the basis of Product and Service, End-Use, and region.
The industry has further divided into software and solutions based on products and services. The software market is further subdivided into on-premise and cloud-based technology. Among these, the industry was driven by the software category. The services category, on the contrary hand, is expected to grow at a faster rate over the projection timeframe due to increased usage of software applications in medical facilities.
The disease surveillance services industry is divided into several segments depending on end-user: long-term care institutions, hospitals, and other end users. In 2020, hospitals held the greatest proportion of the disease surveillance system market. The high patient number, growing prevalence of HAIs, and rising rates of SSIs all contribute to this section's growth. The COVID-19 outbreak has indeed enhanced infection prevention monitoring solution use.
Regional Landscape
North America is among the world's greatest marketplaces for healthcare innovation development. The region's massive market is mostly attributable to a rising R&D activity in health research. Furthermore, increasing medical expenses in this region are triggering personal hospitals to relocate or combine with impartial medical parties to make groups make broader health services which can widen their facility achieve, liquidity economic growth of magnitude, and resist growing regulatory stresses from the present government. Such factors are driving the advancement of technological innovations in healthcare that in return boosts the industry for disease surveillance systems.
Competitive Landscape:
The industry's competitive environment likewise has been explored, as have the biographies of the top competitors, which include Becton Dickinson and Company, Baxter International Inc., Ecolab Inc., Cerner Corporation, Centrak Inc. (Halma plc), CKM Healthcare Incorporated, and others. Important tactics used by companies in the Disease Surveillance System Industry include new products, acquires and agreements, partnerships, and regional growth.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET KEY PLAYERS
- Atlas Medical Software (Rpoer Technologies)
- Baxter International
- BD Diagnostics
- Becton Dickson & Company
- bioMerieux, Inc.
- Cerner Corporation
- DEB Group Ltd.
- Emerald Health Information Systems Ltd
- Gojo Industries, Inc.
- Hygreen Inc.
- Iatric Systems, Inc.
- ICNet Systems, Inc. (Baxter International)
- PeraHealth Inc.
- Premier, Inc.
- Quantros, Inc.
- RL Solutions
- Truven Health Analytics Inc. (IBM Watson)
- Vecna Technologies, Inc.
- Vigilanz Corporation
- Wolters Kluwer N.V.
GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT AND SERVICE
- Software
- Web-Based
- On-Premise
- Services
- Implementation Services
- Product Support & Maintenance
- Training & Consulting services
GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END-USE
- Hospitals
- Medical
- Long Term Care Facilities
- Others (Clinics, and Ambulatory Surgical Centers)
GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
1. Infection Surveillance Solutions Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. Market Snippet by Product and service
2.1.2. Market Snippet by End-Use
2.1.3. Market Snippet by Region
2.2. Competitive Insights
3. Infection Surveillance Solutions Key Market Trends
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. Infection Surveillance Solutions Industry Study
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Infection Surveillance Solutions Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Infection Surveillance Solutions Market Landscape
6.1. Market Share Analysis, 2020
6.2. Key Innovators Analysis
6.3. Breakdown Data, by Key Manufacturer
6.3.1. Established Players’ Analysis
6.3.2. Emerging Players’ Analysis
7. Infection Surveillance Solutions Market – By Product and Service
7.1. Overview
7.1.1. Segment Share Analysis, By Product and service, 2020 & 2027 (%)
7.2. Software
7.2.1. Web-Based
7.2.2. On-Premise
7.3. Services
7.3.1. Implementation Services
7.3.2. Product Support & Maintenance
7.3.3. Training & Consulting services
8. Infection Surveillance Solutions Market – By End-Use
8.1. Overview
8.1.1. Segment Share Analysis, By End-Use, 2020 & 2027 (%)
8.2. Hospitals
8.3. Medical
8.4. Long Term Care Facilities
8.5. Others (Clinics, and Ambulatory Surgical Centers)
9. Infection Surveillance Solutions Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
9.2. North America
9.2.1. Overview
9.2.2. Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
9.2.4. North America Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.2.5. North America Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.3.5. Europe Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.3.7. Italy
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.3.7.3. Italy Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.3.7.4. Italy Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.3.8. United Kingdom
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.3.8.3. United Kingdom Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.3.8.4. United Kingdom Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.3.9. France
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.3.9.3. France Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.3.9.4. France Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.3.10. Rest of Europe
9.3.10.1. Overview
9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.3.10.3. Rest of the Europe Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.3.10.4. Rest of the Europe Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.4.6.4. India Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.4.7.4. China Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.4.8.3. Japan Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.4.8.4. Japan Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.4.9.3. South Korea Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.4.9.4. South Korea Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.4.10. Rest of APAC
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.4.10.3. Rest of APAC Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.4.10.4. Rest of APAC Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.5.9. Rest of LATAM
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.5.9.3. Rest of LATAM Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.5.9.4. Rest of LATAM Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Product and service, 2016 - 2027 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By End-Use, 2016 - 2027 (US$ Million)
10. Key Vendor Analysis
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Atlas Medical Software (Rpoer Technologies)
10.2.2. Baxter International
10.2.3. BD Diagnostics
10.2.4. Becton Dickson & Company
10.2.5. bioMerieux, Inc.
10.2.6. Cerner Corporation
10.2.7. DEB Group Ltd.
10.2.8. Emerald Health Information Systems Ltd
10.2.9. Gojo Industries, Inc.
10.2.10. Hygreen Inc.
10.2.11. Iatric Systems, Inc.
10.2.12. ICNet Systems, Inc. (Baxter International)
10.2.13. PeraHealth Inc.
10.2.14. Premier, Inc.
10.2.15. Quantros, Inc.
10.2.16. RL Solutions
10.2.17. Truven Health Analytics Inc. (IBM Watson)
10.2.18. Vecna Technologies, Inc.
10.2.19. Vigilanz Corporation
10.2.20. Wolters Kluwer N.V.
11. 360 Degree AnalystView
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
